Genmab — Februar 2017
-
Hej alle, Vil meget gerne have spørgsmål til Q&A ind så hurtigt som muligt. http://www.proinvestor.com/index.php?p=q-and-a&groupid=78
-
Europe ready to embrace
first copies of biotech cancer drugs -Reuters: http://uk.reuters.com/article/us-health-pharmaceuticals-biosimilars-idUKKBN15U13E?utm_campaign=trueAnthem:+Trending+Content&utm_content=58a4590804d3015821d2b915&utm_medium=trueAnthem&utm_source=twitter -
Bibob...De skal stille spørgsmålet i Q&A chatten.
-
I JNJ-61186372 fase 1 er forventet patientantal blevet skåret ned til 40 fra før 50. https://clinicaltrials.gov/ct2/show/NCT02609776?term=jnj+bispecific&rank=1
-
Der er gang i spekulationerne: http://medwatch.dk/Medicinal___Biotek/article9367884.ece
-
@gentogen. Er det godt eller skidt at patientantal går fra 50 til 40?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
